Nektar Therapeutics Reports Financial Results for the Second Quarter of 2019
Go back to Nektar Therapeutics Reports Financial Results for the Second Quarter of 2019| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 66.51 +0.81 (1.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.70 | 52 Week High | $19.98 | |||
| Open | $64.10 | 52 Week Low | $10.52 | |||
| Day High | $67.00 | P/E | N/A | |||
| Day Low | $64.10 | EPS | $-1.45 | |||
| Volume | 255,604 | |||||
